Defining the genome-wide mutagenic impact of APOBEC3 enzymes

Area of Science:

• Oncology
• Genetics
• Immunology

Background:

• Somatic mutations are key drivers of cancer initiation and evolution.
• Understanding mutagenesis etiology is vital for cancer prevention and treatment.
• The APOBEC3 (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3) family of innate immune enzymes can aberrantly mutate the cellular genome.

Purpose of the Study:

• To comprehensively define the consequences of APOBEC3 mutagenesis.
• To establish an experimental pipeline for prospective analysis of genome-wide mutations caused by APOBEC3 activity.

Main Methods:

• Development of a novel experimental pipeline for analyzing APOBEC3-driven mutagenesis.
• Genome-wide prospective analysis of mutations.

Main Results:

• APOBEC3 enzymes are a significant source of mutagenesis across various human tumors.
• Single base substitution (SBS) signatures reveal widespread APOBEC3 activity in cancer genomes.

Conclusions:

• The developed pipeline enables detailed study of APOBEC3-induced mutations.
• This methodology can be adapted to investigate other sources of mutagenesis in diverse cell types.